# Sodium Chloride

## Sodium chloride 0.9% inj 1000mL

| TAH Drug Code      | [INS1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INS1)   |
|:-------------------|:-----------------------------------------------------------------------|
| Indications        | 為食鹽水沖洗液(A001085209)                                             |
| Dosing             | Individualized dosage.                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                          |
| Renal Impairment   | Dose adjustment not necessary                                          |
| Contraindications  | No Data                                                                |
| Adverse Effects    | No Data                                                                |
| Pregnancy          | Unknown                                                                |
| Lactation          | Unknown                                                                |

## Isotonic NaCl inj 20mL

| TAH Drug Code      | [INS2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INS2)   |
|:-------------------|:-----------------------------------------------------------------------|
| Indications        | 為生理食鹽水(N009997238)                                               |
| Dosing             | 20-1000 mL SC/IV/IV infusion. May use as diluent.                      |
| Hepatic Impairment | Dose adjustment not necessary                                          |
| Renal Impairment   | Dose adjustment not necessary                                          |
| Contraindications  | No Data                                                                |
| Adverse Effects    | No Data                                                                |
| Pregnancy          | Unknown                                                                |
| Lactation          | Unknown                                                                |

## 0.9% NaCl inj 250mL

| TAH Drug Code      | [INS250](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INS250)   |
|:-------------------|:---------------------------------------------------------------------------|
| Indications        | 為生理食鹽水注射液(A001085265)                                             |
| Dosing             | Individualized dosage.                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                              |
| Renal Impairment   | Dose adjustment not necessary                                              |
| Contraindications  | No Data                                                                    |
| Adverse Effects    | No Data                                                                    |
| Pregnancy          | Unknown                                                                    |
| Lactation          | Unknown                                                                    |

## 3% NaCl inj 500mL

| TAH Drug Code      | [INS3](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INS3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | ■Corneal edema ■Hyponatremia ■Hypovolemic shock                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | Adult Parenteral nutrition: Sodium maintenance electrolyte requirement: IV: 1 to 2 mEq/kg/24 hours; customize amounts based on individual patient needs. Acute hyponatremia (serum sodium <130 mEq/L): Asymptomatic: IV 50 mL bolus over at least 5 minutes; monitor serum sodium every 1-2 hrs to assess need for additional treatment. Symptomatic: IV 100 mL over 10 minutes; if symptoms persist, may repeat up to a total of 3 doses over a period of 30 minutes; monitor serum sodium hourly to assess need for repeat treatment. Chronic hyponatremia Asymptomatic or mild to moderate symptoms, severe hyponatremia (serum sodium <120 mEq/L): IV Initial: 15 to 30 mL/hr with frequent (eg, every 2 to 4 hrs) serum sodium monitoring; or alternatively, 1 mL/kg bolus (maximum bolus: 100 mL) over 10 minutes every 6 hrs as needed. Severe symptoms (eg, seizures, obtundation, coma, respiratory arrest) or known intracranial pathology: IV 100 mL over 10 minutes; if symptoms persist, may repeat up to a total of 3 doses over a period of 30 minutes, Alternatively, some experts recommend 150 mL over 20 minutes, up to a total of 2 doses while measuring serum sodium between infusions. Hyponatremia in neonate: 3%NaCl infusion rate about 0.1-1 ml/kg/hour (max infusion rate 1 ml/kg/hour) and a central line is preferred for administration for 3% NaCl. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Hypersensitivity to sodium chloride or any component of the formulation; hypertonic uterus, hypernatremia, fluid retention                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | common ■Cardiovascular: Phlebitis ■Dermatologic: Injection site extravasation, Injection site reaction ■Endocrine metabolic: Hypervolemia serious ■Cardiovascular: Congestive heart failure ■Endocrine metabolic: Hypernatremia, Overhydration ■Hematologic: Disseminated intravascular coagulation ■Respiratory: Respiratory distress                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

## 0.45% Saline inj 500mL

| TAH Drug Code      | [INS45](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INS45)   |
|:-------------------|:-------------------------------------------------------------------------|
| Indications        | 為0.45 % 食鹽水注射液(A036014277)                                        |
| Dosing             | IV infusion as needed.                                                   |
| Hepatic Impairment | Dose adjustment not necessary                                            |
| Renal Impairment   | Dose adjustment required                                                 |
| Contraindications  | No Data                                                                  |
| Adverse Effects    | No Data                                                                  |
| Pregnancy          | Unknown                                                                  |
| Lactation          | Unknown                                                                  |

## 0.45% NaCl inj 20mL (限RT使用)

| TAH Drug Code      | [INS45/20](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INS45/20)   |
|:-------------------|:-------------------------------------------------------------------------------|
| Indications        | No Data                                                                        |
| Dosing             | Only for respiratory treatment of in-patient.                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                  |
| Contraindications  | No Data                                                                        |
| Adverse Effects    | No Data                                                                        |
| Pregnancy          | Unknown                                                                        |
| Lactation          | Unknown                                                                        |

## 0.9% NaCl inj 500mL

| TAH Drug Code      | [INS5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INS5)   |
|:-------------------|:-----------------------------------------------------------------------|
| Indications        | 為生理食鹽水注射液(A001085277)                                         |
| Dosing             | IV infusion as needed.                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                          |
| Renal Impairment   | Dose adjustment not necessary                                          |
| Contraindications  | No Data                                                                |
| Adverse Effects    | No Data                                                                |
| Pregnancy          | Unknown                                                                |
| Lactation          | Unknown                                                                |

## 0.9% NaCl 100mL bag(Otsuka)

| TAH Drug Code      | [INSO100](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INSO100)                                                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Water or electrolyte replenishment.                                                                                                                                                                                                                                                                                             |
| Dosing             | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L.                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Hypernatremic and fluid retention syndromes. Immediately following surgery.                                                                                                                                                                                                                                                     |
| Adverse Effects    | Common Cardiovascular: Phlebitis Dermatologic: Injection site extravasation, Injection site reaction Endocrine metabolic: Hypervolemia Serious Cardiovascular: Congestive heart failure Endocrine metabolic: Hypernatremia, Overhydration Hematologic: Disseminated intravascular coagulation Respiratory: Respiratory distress |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                         |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                         |

## 0.9% NaCl 250mL bag(Otsuka)

| TAH Drug Code      | [INSO250](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INSO250)                                                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Water or electrolyte replenishment.                                                                                                                                                                                                                                                                                             |
| Dosing             | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L.                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Hypernatremic and fluid retention syndromes. Immediately following surgery.                                                                                                                                                                                                                                                     |
| Adverse Effects    | Common Cardiovascular: Phlebitis Dermatologic: Injection site extravasation, Injection site reaction Endocrine metabolic: Hypervolemia Serious Cardiovascular: Congestive heart failure Endocrine metabolic: Hypernatremia, Overhydration Hematologic: Disseminated intravascular coagulation Respiratory: Respiratory distress |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                         |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                         |

## 0.9% NaCl 500mL bag(Otsuka)

| TAH Drug Code      | [INSO5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INSO5)                                                                                                                                                                                                                                                          |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Water or electrolyte replenishment.                                                                                                                                                                                                                                                                                             |
| Dosing             | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L.                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Hypernatremic and fluid retention syndromes. Immediately following surgery.                                                                                                                                                                                                                                                     |
| Adverse Effects    | Common Cardiovascular: Phlebitis Dermatologic: Injection site extravasation, Injection site reaction Endocrine metabolic: Hypervolemia Serious Cardiovascular: Congestive heart failure Endocrine metabolic: Hypernatremia, Overhydration Hematologic: Disseminated intravascular coagulation Respiratory: Respiratory distress |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                         |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                         |

